When you compare the Regeneron's (REGN) DSMB's recommendations out today to CYDY's DSMB's recommendations, you see that CYDY's DSMB's recommendations were a 10 out of 10. Regeneron told to stop taking any further high flow oxygen and mechanical ventilation patients into their clinical trial. Is CYDY the only company still left for the most severe?